Pfizer Ltd Financials

Pfizer Ltd Financial Statement

Pfizer Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Sep 2024	Jun 2024	Mar 2024
Revenue	631.66	604.70	621.76
Operating Expense	399.34	385.37	357.20
Net Profit	158.35	150.71	178.86
Net Profit Margin	25.07	24.92	28.77
Earning Per Share	34.61	32.94	39.09
EBIDTA	235.33	222.47	248.25
Effective Tax Rate	25.78	25.10	18.40

Particulars	Sep 2024
Revenue	631.66
Operating Expense	399.34
Net Profit	158.35
Net Profit Margin	25.07
Earning Per Share	34.61
EBIDTA	235.33
Effective Tax Rate	25.78

Pfizer Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Total Revenue Annual	2,193.17	2,424.76	2,610.99
Operating Expenses Annual	1,557.87	1,615.90	1,775.26
Operating Profit Annual	823.76	942.91	898.38
Interest Annual	15.41	13.39	10.49
Depreciation	52.32	55.19	64.68
Net Profit Annual	551.33	623.93	612.56
Tax Annual	194.74	200.08	160.33

Particulars	Mar 2024
Total Revenue Annual	2,193.17
Operating Expenses Annual	1,557.87
Operating Profit Annual	823.76
Interest Annual	15.41
Depreciation	52.32
Net Profit Annual	551.33
Tax Annual	194.74

Pfizer Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Cash Flow at the Beginning	36.60	62.76	151.21
Cash Flow from Operations	256.84	355.68	667.08
Cash Flow from Investing	53.70	-36.05	-575.02
Cash Flow from Financing	-235.14	-345.79	-180.51
Cash Flow at the End	112	36.60	62.76

Particulars	Mar 2024
Cash Flow at the Beginning	36.60
Cash Flow from Operations	256.84
Cash Flow from Investing	53.70
Cash Flow from Financing	-235.14
Cash Flow at the End	112

Pfizer Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
PBDIT Margin (%)	37.56	38.89	34.42
PBIT Margin (%)	34.72	34.54	30.01
PBT Margin (%)	32.47	31.98	27.21
Net PROFIT Margin (%)	25.14	25.73	23.46
Return On Networth / Equity (%)	16.21	20.55	23.30
Return On Networth /Employed (%)	21.43	25.88	27.78
Return On Assets (%)	15.59	19.30	21.82
Total Debt / Equity (X)	0.01	0.01	0.02
Asset Turnover Ratio (%)	0.62	0.75	0.93

Particulars	Mar 2024
PBDIT Margin (%)	37.56
PBIT Margin (%)	34.72
PBT Margin (%)	32.47
Net PROFIT Margin (%)	25.14
Return On Networth / Equity (%)	16.21
Return On Networth /Employed (%)	21.43
Return On Assets (%)	15.59
Total Debt / Equity (X)	0.01
Asset Turnover Ratio (%)	0.62

Pfizer Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Fixed Assets Annual	712.71	749.25	840.96
Total Current Assets Annual	2,737.81	2,493.34	2,396.48
Non Current Assets Annual	1,459.22	1,475.64	1,504.03
Total Shareholders Funds Annual	3,595.54	3,207.30	2,864.41
Total Assets Annual	4,228.78	4,000.73	3,900.51

Particulars	Mar 2024
Fixed Assets Annual	712.71
Total Current Assets Annual	2,737.81
Non Current Assets Annual	1,459.22
Total Shareholders Funds Annual	3,595.54
Total Assets Annual	4,228.78

Pfizer Ltd Earning Calls

No Data Availabe

Dividend Pages

PE Ratio

Get Your FAQs Right

As of Dec 26, 2024, Pfizer Ltd has a market capitalization of 19,184.08 Cr. Value Research classifies it as a Large-Cap company.

Yes, Pfizer Ltd is debt-free with a debt-to-equity ratio of 0.01.

In FY 2023 , Pfizer Ltd recorded a total revenue of approximately 2,193.17 Cr marking a significant milestone in the company's financial performance.

Pfizer Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.0% and -0.1% annually, respectively..

Pfizer Ltd's current PE ratio is 34.80.

Pfizer Ltd's ROCE averaged 23.8% from the FY ending March 2022 to 2024, with a median of 25.1%. It peaked at 25.8% in March 2022, reflecting strong capital efficiency over the period..

Pfizer Ltd's latest EBIT is Rs. 761.48 Cr, surpassing the average EBIT of Rs. 794.09 Cr over the 5 years..